StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3076% above fair value
$266.17−4.39 (-1.62%)

Close on Nov 3, 2026Market cap $641.44BP/E 40.4Yield 1.93%

Johnson & Johnson Wound Care / Other (BAND-AID) by Year

Wound Care / Other (BAND-AID) — U.S. operational growth YoY (%) (%)

Johnson & Johnson Wound Care / Other (BAND-AID): -4.0% in FY2022, down 7.1 pts from a year earlier. No newer figure appears in the documents we track.

Latest, FY2022
-4.0%
Period ended Jan 1, 2023
Change on a year earlier
-7.1 pts
3.1% in FY2021
History
6 years
Since FY2017
Sources
6
Documents cited below

Where the FY2022 figure comes from

“|| US | 475 | 495 | (4.0) | (4.0) | —”

Source: Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWound Care / Other (BAND-AID) — U.S. operational growth YoY (%) (%)Year on yearSource
FY2022Jan 1, 2023-4.0%-7.1 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
FY2021Jan 2, 20223.1%-5.8 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
FY2020Jan 3, 20218.9%+7.7 ptsForm 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
FY2019Dec 29, 20191.2%+1.4 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 2018-0.2%+3.8 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 2017-4.0%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Wound Care / Other (BAND-AID) (%), annual FY2017–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch-wound-care-us-ops-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.

See a number that looks wrong?